Cardio Diagnostics (CDIO) Competitors $3.82 0.00 (-0.03%) As of 03:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDIO vs. RLYB, ASBP, ENLV, FBLG, NNVC, ALVR, PASG, NEUP, PMN, and NAIIShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include Rallybio (RLYB), Aspire Biopharma (ASBP), Enlivex Therapeutics (ENLV), FibroBiologics (FBLG), NanoViricides (NNVC), AlloVir (ALVR), Passage Bio (PASG), Neuphoria Therapeutics (NEUP), Promis Neurosciences (PMN), and Natural Alternatives International (NAII). These companies are all part of the "pharmaceutical products" industry. Cardio Diagnostics vs. Its Competitors Rallybio Aspire Biopharma Enlivex Therapeutics FibroBiologics NanoViricides AlloVir Passage Bio Neuphoria Therapeutics Promis Neurosciences Natural Alternatives International Rallybio (NASDAQ:RLYB) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership. Does the media prefer RLYB or CDIO? In the previous week, Rallybio had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 2 mentions for Rallybio and 1 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.91 beat Rallybio's score of 1.45 indicating that Cardio Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment Rallybio Positive Cardio Diagnostics Very Positive Is RLYB or CDIO more profitable? Rallybio has a net margin of -5,473.33% compared to Cardio Diagnostics' net margin of -30,465.10%. Rallybio's return on equity of -71.66% beat Cardio Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Rallybio-5,473.33% -71.66% -65.06% Cardio Diagnostics -30,465.10%-72.78%-66.17% Which has stronger earnings & valuation, RLYB or CDIO? Cardio Diagnostics has lower revenue, but higher earnings than Rallybio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRallybio$640K38.39-$57.78M-$0.94-0.63Cardio Diagnostics$40K168.04-$8.38MN/AN/A Do insiders & institutionals hold more shares of RLYB or CDIO? 90.3% of Rallybio shares are owned by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are owned by institutional investors. 8.7% of Rallybio shares are owned by company insiders. Comparatively, 13.3% of Cardio Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts recommend RLYB or CDIO? Rallybio currently has a consensus target price of $5.00, suggesting a potential upside of 750.34%. Given Rallybio's stronger consensus rating and higher possible upside, equities research analysts plainly believe Rallybio is more favorable than Cardio Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rallybio 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, RLYB or CDIO? Rallybio has a beta of -1.1, indicating that its share price is 210% less volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 2.94, indicating that its share price is 194% more volatile than the S&P 500. SummaryRallybio beats Cardio Diagnostics on 8 of the 13 factors compared between the two stocks. Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIO vs. The Competition Export to ExcelMetricCardio DiagnosticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.71M$3.15B$5.82B$10.17BDividend YieldN/A2.32%5.69%4.60%P/E RatioN/A21.4374.6725.98Price / Sales168.04256.94454.5485.61Price / CashN/A45.3337.0859.91Price / Book0.549.6512.186.31Net Income-$8.38M-$53.29M$3.29B$270.86M7 Day Performance2.94%0.44%1.08%3.46%1 Month Performance2.11%9.06%7.32%6.57%1 Year Performance-56.31%13.13%63.11%28.39% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOCardio Diagnostics1.4726 of 5 stars$3.820.0%N/A-56.2%$6.71M$40K0.001Positive NewsGap UpRLYBRallybio3.4014 of 5 stars$0.59-2.4%$5.00+741.6%-46.7%$25.43M$640K-0.6340Positive NewsShort Interest ↓ASBPAspire BiopharmaN/A$0.510.0%N/AN/A$25.35MN/A0.00N/APositive NewsENLVEnlivex Therapeutics2.553 of 5 stars$1.04-1.9%$10.00+861.5%-17.7%$25.07MN/A-1.7970News CoverageAnalyst ForecastShort Interest ↑FBLGFibroBiologics3.0882 of 5 stars$0.57-0.9%$13.00+2,183.1%-83.5%$24.06MN/A-1.5810News CoverageAnalyst ForecastNNVCNanoViricides0.1519 of 5 stars$1.44-3.4%N/A-12.3%$23.95MN/A-2.0020Positive NewsShort Interest ↑ALVRAlloVirN/A$4.62-0.9%N/A-73.8%$23.30MN/A-0.23110High Trading VolumePASGPassage Bio3.9394 of 5 stars$7.12-0.8%$75.67+962.9%-54.5%$22.82MN/A-0.39130NEUPNeuphoria Therapeutics2.5805 of 5 stars$12.99+9.3%$21.00+61.7%N/A$22.35M$10K0.00N/ANews CoverageAnalyst ForecastPMNPromis Neurosciences3.6947 of 5 stars$0.44+1.6%$4.33+891.6%-66.0%$22.28MN/A-2.085Positive NewsShort Interest ↓NAIINatural Alternatives International1.6732 of 5 stars$3.41-5.3%N/A-43.7%$22.24M$125.48M-2.45290Positive NewsShort Interest ↓Gap DownHigh Trading Volume Related Companies and Tools Related Companies RLYB Competitors ASBP Competitors ENLV Competitors FBLG Competitors NNVC Competitors ALVR Competitors PASG Competitors NEUP Competitors PMN Competitors NAII Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDIO) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDIO Stock Alerts